EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma

Rikke B Holmstroem, Sidsel Pedersen, Rebecca Jurlander, Kasper Madsen, Marco Donia, Christina H Ruhlmann, Henrik Schmidt, Charlotte A Haslund, Lars Bastholt, Inge Marie Svane, Eva Ellebaek

European Journal of Cancer · 2024-05 · 202 · 114023

DOI: 10.1016/j.ejca.2024.114023 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2024-05. Verfasst von Rikke B Holmstroem und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kraeftens Bekaempelse, Sundhedsstyrelsen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansNivolumabIpilimumabAdjuvants, ImmunologicImmunotherapy

Stichwörter der Autor:innen

Adjuvant immunotherapyAnti-PD-1MelanomaMelanoma recurrenceNivolumabPembrolizumab

Substanzen

NivolumabIpilimumabAdjuvants, Immunologic

Autor:innen und Institutionen

  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark.
  • Department of Oncology, Odense University Hospital, Denmark.
  • Department of Oncology, Aarhus University Hospital, Denmark.
  • Department of Oncology, Aalborg University Hospital, Denmark.
  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Electronic address: inge.marie.svane@regionh.dk.
  • National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Electronic address: eva.ellebaek.steensgaard@regionh.dk.

Förderung

  • Kraeftens Bekaempelse
  • Sundhedsstyrelsen

Zitieren

APA

Holmstroem, R. B., Pedersen, S., Jurlander, R., Madsen, K., Donia, M., Ruhlmann, C. H., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, I. M., & Ellebaek, E. (2024). Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma. European Journal of Cancer, 202, 114023. https://doi.org/10.1016/j.ejca.2024.114023

Vancouver

Holmstroem RB, Pedersen S, Jurlander R, Madsen K, Donia M, Ruhlmann CH, et al. Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma. European Journal of Cancer. 2024;202:114023. doi:10.1016/j.ejca.2024.114023

BibTeX
@article{Holmstroem2024,
  author = {Holmstroem, Rikke B and Pedersen, Sidsel and Jurlander, Rebecca and Madsen, Kasper and Donia, Marco and Ruhlmann, Christina H and Schmidt, Henrik and Haslund, Charlotte A and Bastholt, Lars and Svane, Inge Marie and Ellebaek, Eva},
  title = {Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {202},
  pages = {114023},
  doi = {10.1016/j.ejca.2024.114023}
}
Kostenlos starten →